Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Ribavirin
gptkb:ribavirin |
| gptkbp:activities |
inhibits viral RNA synthesis
|
| gptkbp:brand |
gptkb:Copegus
|
| gptkbp:can_be_used_with |
gptkb:peginterferon
|
| gptkbp:clinical_trial |
Phase III
|
| gptkbp:contraindication |
pregnancy
severe renal impairment |
| gptkbp:dosage_form |
gptkb:tablet
|
| gptkbp:duration |
24 to 48 weeks
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Copegus
|
| gptkbp:ingredients |
gptkb:ribavirin
|
| gptkbp:interacts_with |
gptkb:didanosine
gptkb:zidovudine |
| gptkbp:is_used_for |
treatment of hepatitis C
|
| gptkbp:lifespan |
approximately 12 hours
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Schering-Plough
|
| gptkbp:marketed_as |
gptkb:2001
|
| gptkbp:metabolism |
liver
|
| gptkbp:packaging |
gptkb:beer
|
| gptkbp:previous_name |
gptkb:ribavirin
|
| gptkbp:requires |
gptkb:theorem
|
| gptkbp:side_effect |
gptkb:fandom
fatigue headache nausea |
| gptkbp:storage |
room temperature
|